Back to News
Market Impact: 0.25
Ginkgo Datapoints Partners With Lilly TuneLab To Link AI Models And Lab Data
Source: Nasdaq
Artificial IntelligenceHealthcare & BiotechTechnology & Innovation
Ginkgo Bioworks announced a new agreement for its Ginkgo Datapoints offering with Lilly TuneLab, Eli Lilly's AI/ML drug-discovery platform. The partnership expands Ginkgo's presence in AI-enabled biotechnology and drug discovery, though no financial terms or expected revenue contribution were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
DNA0.50
LLY0.20
More News
- 'Hostile act': Trump threatens EU with tariffs over Canada associate-membership proposal
- US official says upcoming spectrum auctions could generate more than $100 billion
- Investors react to Fed hike and market sell-off: Brace for 'higher for longer' rates
- Fed delivers its first hike in 3 years. Plus, what's moving Starbucks and GE Vernova
- Fed’s Warsh lays out forces driving up bond yields
- The Fed unanimously agrees to hike interest rates for the first time since 2023, despite Trump’s call for the ‘lowest rates’ in the world